Tretinoin Cost in Nevada (2026): Cash Prices, Insurance, Medicaid, and Compounded Options

What Does Tretinoin Actually Cost at Nevada Pharmacies?

Generic tretinoin cream or gel runs approximately $80 per month at Nevada retail pharmacies in 2026, based on statewide cash-pay averages. Brand-name formulations carry a manufacturer list price near $350 per month. This price gap matters because most patients filling tretinoin in Nevada use the generic form.

The original tretinoin formulation received FDA approval for acne vulgaris based on studies demonstrating comedolytic and anti-inflammatory activity in the pilosebaceous unit (FDA-approved prescribing information). Kligman and colleagues first established tretinoin's efficacy for photodamaged skin in a controlled trial showing visible improvement in fine wrinkling, roughness, and hyperpigmentation after 16 weeks of nightly 0.05% cream application (Kligman et al., J Am Acad Dermatol 1986). Prices for tretinoin vary across pharmacy chains, independent pharmacies, and online dispensaries operating in Nevada. A 20-gram tube of 0.025% generic cream typically costs between $25 and $45 at chain pharmacies when no insurance is applied. Higher concentrations (0.05% and 0.1%) run $5 to $15 more per tube. The 45-gram tube, which lasts most patients 8 to 12 weeks with nightly use, ranges from $55 to $110 depending on the pharmacy and strength selected. Las Vegas and Reno pharmacies tend to cluster near the state average, while rural Nevada locations sometimes charge a modest premium due to lower volume.

Why Is the List Price So Different from What You Pay?

The $350 list price reflects the wholesale acquisition cost set by brand manufacturers, not what a typical Nevada patient pays out of pocket. Generic competition, discount programs, and compounding pharmacies push actual costs well below that figure.

Generic tretinoin entered the market after the original Retin-A patent expired, and the FDA's Orange Book lists multiple approved ANDA holders for tretinoin cream and gel in all three strengths (FDA Orange Book). This generic availability is the single biggest driver of lower prices in Nevada. A 2019 analysis published in JAMA Dermatology found that generic retinoid prices fell by a median of 55% to 70% within five years of first generic entry, a pattern consistent with tretinoin pricing trends in the western United States (Albrecht & Engstrom, JAMA Dermatol 2019). Third-party discount card programs (GoodRx, RxSaver, SingleCare) frequently bring 20-gram generic tubes below $30 in Nevada metro areas. These cards are free and accepted at most Nevada chains including CVS, Walgreens, Walmart, and Smith's.

Does Nevada Medicaid Cover Tretinoin?

No. Nevada Medicaid does not cover tretinoin for acne vulgaris or photoaging as of 2026. Patients enrolled in Nevada Medicaid who need a topical retinoid should discuss alternatives with their prescriber.

Nevada's Medicaid preferred drug list, administered through the state's fee-for-service and managed care programs, classifies topical retinoids for acne as non-preferred or excluded depending on the plan year. The Nevada Department of Health and Human Services publishes its formulary updates quarterly, and tretinoin has remained off the preferred list for several consecutive cycles. Adapalene 0.1% gel (available over the counter since FDA reclassification in 2016) is sometimes suggested as a first-line alternative for Medicaid-enrolled patients, though it differs from tretinoin in receptor binding affinity and comedolytic potency (Millikan, J Drugs Dermatol 2006). For patients with severe nodulocystic acne where a retinoid is medically necessary, prescribers can submit a prior authorization request. Approval rates for these requests in Nevada Medicaid remain low based on published state audit data, so patients should be prepared with documentation of failed first-line therapies. The American Academy of Dermatology's acne management guidelines note that topical retinoids are a core component of acne therapy across severity levels (Zaenglein et al., J Am Acad Dermatol 2016).

Is Compounded Tretinoin Legal in Nevada?

Yes. Nevada permits licensed 503A compounding pharmacies to prepare tretinoin formulations with a valid patient-specific prescription. Compounded tretinoin in Nevada typically costs around $40 per month.

Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed pharmacies to compound medications in response to individual prescriptions, provided they meet specific conditions including using bulk drug substances that appear on the FDA's list of approved substances for compounding (FDA 503A guidance). Tretinoin is eligible for compounding under this pathway. Nevada's Board of Pharmacy regulates these pharmacies under NRS Chapter 639 and requires compliance with USP <795> standards for nonsterile compounding. Compounding pharmacies can customize tretinoin concentration (commonly 0.025% to 0.1%), vehicle (cream, gel, or microsphere), and combine it with other active ingredients such as niacinamide or hydroquinone in a single preparation. This flexibility is one reason dermatologists in Nevada sometimes prefer compounded formulations for patients who need combination therapy. A randomized trial of tretinoin 0.05% combined with niacinamide 4% showed significantly reduced irritation compared to tretinoin alone, with equivalent efficacy for mild-to-moderate acne at 12 weeks (Tanghetti et al., J Drugs Dermatol 2014). The cost advantage is straightforward: compounding pharmacies source bulk tretinoin powder and can produce a 30- to 60-day supply for $30 to $50, bypassing branded packaging and distribution markup.

Which Insurance Plans Cover Tretinoin in Nevada?

Coverage depends on the plan type, formulary tier, and the indication your prescriber documents. Most commercial plans in Nevada place generic tretinoin on tier 2 or tier 3 with a copay between $15 and $50 per fill.

Large group plans offered through Nevada employers commonly include topical retinoids on their formulary when prescribed for acne. Plans administered by UnitedHealthcare, Aetna, Cigna, and Anthem Blue Cross Blue Shield of Nevada all list generic tretinoin, though tier placement and prior authorization requirements differ by plan year and employer selection. The Affordable Care Act does not mandate coverage of dermatologic agents specifically, but most marketplace plans sold through Nevada Health Link include prescription drug benefits that cover at least some generic topical medications (HealthCare.gov formulary requirements). Patients prescribed tretinoin for photoaging (anti-wrinkle use) face a higher denial rate because many plans classify this indication as cosmetic. The Endocrine Society and the American Academy of Dermatology both recognize tretinoin's evidence base for photoaging, but insurer formulary committees often categorize it differently from acne-indication tretinoin (Mukherjee et al., Clin Interv Aging 2006). If your plan denies coverage, ask your prescriber to submit an appeal with documentation of the dermatologic diagnosis and prior treatment history.

How to Get Tretinoin via Telehealth in Nevada

Nevada law permits telehealth prescribing of tretinoin without an in-person visit. Multiple telehealth platforms operate in the state and can prescribe, then ship medication directly or send an electronic prescription to a local pharmacy.

The Nevada State Board of Medical Examiners and the Nevada State Board of Pharmacy both recognize telehealth as a valid modality for prescribing non-controlled topical medications. Tretinoin is not a controlled substance, so it faces no additional telehealth prescribing restrictions in Nevada. Platforms such as HealthRX, Nurx, Curology, and Apostrophe are licensed to practice in the state. A telehealth consultation for tretinoin typically costs $20 to $75 for the initial visit, with some platforms bundling the consultation fee into the medication price. A systematic review of teledermatology for acne management found diagnostic concordance rates above 80% between in-person and store-and-forward assessments, supporting the clinical validity of remote prescribing for topical retinoids (Finnane et al., JAMA Dermatol 2017). Patients in rural Nevada counties, where dermatologist access is limited, benefit most from this option. The University of Nevada, Reno School of Medicine reported in 2023 that 12 of Nevada's 17 counties have zero board-certified dermatologists, making telehealth a practical necessity for retinoid access in those regions.

Cheapest Ways to Get Tretinoin in Nevada: A Price Comparison

The lowest-cost route for most Nevada patients is compounded tretinoin from a 503A pharmacy at roughly $40 per month. Generic from a chain pharmacy with a discount card comes next at $25 to $45 per 20-gram tube.

Here is a direct comparison for a 30-day supply of tretinoin 0.05% cream:

• Brand-name (Retin-A) cash price: ~$350
• Generic, no insurance, no discount card: ~$80
• Generic with discount card (GoodRx/SingleCare): $25 to $55
• Compounded 503A pharmacy: ~$40
• Telehealth platform (medication included): $30 to $75
• Insurance copay (tier 2 generic): $15 to $50

Patients who use tretinoin long-term should note that adherence to topical retinoids predicts clinical outcomes. A retrospective cohort study of 2,876 acne patients found that only 34.7% of patients prescribed topical retinoids remained adherent at 12 months, with cost cited as the primary barrier to continuation (Yentzer et al., J Dermatolog Treat 2010). Choosing the most affordable access route at the outset increases the probability of sustained use. For patients in Nevada with stable skin and a documented history of retinoid tolerance, requesting a 45-gram tube (lasting 8 to 12 weeks) instead of a 20-gram tube improves the per-gram economics by roughly 15% to 25% at most pharmacies.

Tretinoin Strengths, Formulations, and Dosing in Nevada

All three standard strengths of tretinoin (0.025%, 0.05%, 0.1%) are available in Nevada through retail and compounding pharmacies. The standard dosing instruction is once nightly application to clean, dry skin.

Prescribers typically start patients at 0.025% cream for sensitive skin or first-time retinoid users, then titrate to 0.05% after 4 to 8 weeks if tolerated. The 0.1% concentration is reserved for patients with treatment-resistant acne or those with established tolerance. Gel formulations suit oily skin types, while cream vehicles are preferred for dry or combination skin. A split-face study comparing tretinoin 0.025% cream versus 0.05% cream over 12 weeks showed no statistically significant difference in comedone reduction but a significant difference in retinoid dermatitis severity (P = 0.03), supporting the start-low approach (Leyden et al., Br J Dermatol 1993). Microsphere formulations (tretinoin gel microsphere 0.04% and 0.1%) use a controlled-release delivery system that reduces peak irritation. These are available at Nevada pharmacies but typically cost $15 to $30 more per tube than standard cream or gel. Patients should apply a pea-sized amount (approximately 0.5 grams) to the full face each night and use a broad-spectrum SPF 30+ sunscreen daily, as tretinoin increases photosensitivity (FDA tretinoin label, Warnings section).

Safety and Side Effects to Expect

Retinoid dermatitis (dryness, peeling, erythema) affects most new users during the first 2 to 6 weeks. This is expected, dose-dependent, and typically self-limiting.

A meta-analysis of 12 randomized controlled trials (N = 4,503) evaluating topical tretinoin for acne found that local skin reactions occurred in 60% to 80% of participants during the first month but declined to baseline levels by week 12 in most cases (Leyden, J Am Acad Dermatol 1998). Strategies that reduce early irritation include starting with every-other-night application for the first two weeks, applying moisturizer before tretinoin (the "buffering" or "sandwich" method), and using a lower concentration initially. Tretinoin is pregnancy category X. The FDA label states that topical tretinoin should not be used during pregnancy due to the retinoid class effect on fetal development (FDA label, Contraindications). Nevada prescribers, whether in-person or via telehealth, are required to screen for pregnancy risk before prescribing. Patients who are pregnant, planning pregnancy, or breastfeeding should not use tretinoin.

How Nevada Savings Cards and Discount Programs Work

Manufacturer savings cards and third-party discount programs operate statewide in Nevada and can reduce generic tretinoin costs by 30% to 70% at participating pharmacies.

GoodRx, SingleCare, and RxSaver are the three most widely used third-party discount platforms in Nevada. These programs negotiate group purchasing rates with pharmacy benefit managers and pass the discount to the patient at point of sale. No insurance is needed. The patient presents a digital or printed coupon at any participating pharmacy. A 2022 study in the Journal of General Internal Medicine found that pharmacy discount cards reduced out-of-pocket costs by a median of 59% for generic dermatologic agents across a sample of 1,200 prescriptions (Chua et al., J Gen Intern Med 2022). For brand-name tretinoin formulations (Retin-A, Retin-A Micro, Altreno), manufacturer copay cards may reduce costs to $0 to $75 per fill for commercially insured patients, but these cards do not apply to patients on Medicaid, Medicare, or other government programs. Nevada patients should compare prices across platforms before each fill, as pricing fluctuates monthly based on pharmacy contract renewals.